Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Times Denmark.
Copenhagen Infrastructure Partners secures CfD contract for onshore wind farm in Romania and welcomes the European Investment Bank as co-investor
COPENHAGEN, Denmark, March 13, 2025 (GLOBE NEWSWIRE) -- Today, Copenhagen Infrastructure Partners (CIP) announced that Radramo Power SRL, the company holding the rights to the ~400MW Pestera II onshore wind project, has entered into a binding...
Air Ambulance Market to Hit $21.11 Bn by 2032 | Boosted by eVTOL, Rotary & Fixed-Wing Aircraft, and EMS Demand
The Association of Air Medical Services approximates that over half a million patients in the U. S. require the use of air ambulance annually. WILMINGTON, DE, UNITED STATES, October 9, 2025 /EINPresswire.com/ -- Explore the Air Ambulance...
IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that Mai-Britt Zocca, PhD, the...
Respiratory & Anaesthesia Disposable Market 2024–2032 | Size & Forecast
Respiratory and Anaesthesia Disposable Market revenue is expected to grow at a CAGR of 5.6% from 2025 to 2032, reaching nearly USD 77.94 billion. SACRAMENTO, CA, UNITED STATES, October 15, 2025 /EINPresswire.com/ -- Respiratory and anaesthesia...
Copenhagen Institute for Futures Studies Announces Leadership Changes in Health Team
Aron Szpisjak taking over as head of the health team as Bogi Eliasen moves on to lead Movement Health Foundation as Executive Director. COPENHAGEN, DENMARK, February 28, 2025 /EINPresswire.com/ -- Effective March 1st, Aron assumes leadership of...
Rezilient Health and High Plains Health Plan Partner to Improve Access to Quality and Affordable Healthcare
The basis of this strategic alliance between Rezilient and HPHP is a shared commitment to establish highly-accessible and affordable healthcare. ST. LOUIS, MO, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Rezilient Heath, a leading...
Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health
Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health Proceeds from the financing will advance ReproNovo’s lead candidates RPN-001 (leflutrozole) and RPN-002...
Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025
Press release – No. 8 / 2025 Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025 Copenhagen, Denmark, May 12, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused...
Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights
- Interim data from ENERGY 3 trial highlight INZ-701’s potential to modify disease course in ENPP1 Deficiency, with sustained phosphate increases and favorable safety and immunogenicity profile to date - - ENERGY 3 trial on track for topline data...
NMD Pharma to present compelling preclinical data highlighting the potential of ClC-1 ion channel inhibition to improve disease symptoms and progression in MuSK myasthenia gravis at the MGFA International Conference on Myasthenia and Relate
NMD Pharma to present compelling preclinical data highlighting the potential of ClC-1 ion channel inhibition to improve disease symptoms and progression in MuSK myasthenia gravis at the MGFA International Conference on Myasthenia and Related...
Allarity Therapeutics Announces Participation in Pharma Partnering Summit US
TARPON SPRINGS, Fla., May 12, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway...
Farmasiet, Norway’s largest online pharmacy, signs Agillic for advanced customer engagement
Press release – Copenhagen, 12 May 2025 – Agillic A/S The Norwegian online pharmacy, Farmasiet, signs Agillic for advanced customer engagement to explore untapped business potential. Farmasiet is Norway's largest online pharmacy, delivering...
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025
COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest data from its hypoparathyroidism, achondroplasia, and growth hormone deficiency (GHD) programs during ESPE & ESE...
GenAI in MedTech Market Trends, Applications and Growth Opportunities
Ottawa, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The global GenAI in the medtech market is driven by the expansion of its healthcare applications, growing innovations, increasing R&D activities, and growing diseases. GenAI streamlines workflows,...
Call for Applications: Karger Publishers Opens Submissions for 6th Vesalius Innovation Award to Advance Health Sciences
Karger Publishers is seeking top applicants for its Vesalius Innovation Award aimed at early-stage startups in the Health Sciences and Publishing sectors. BASEL, SWITZERLAND, May 6, 2025 /EINPresswire.com/ -- Now in its sixth year, the Vesalius...
Medical Rehabilitation Services Market Size to Accomplish USD 492.4 Bn by 2034
Ottawa, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The global medical rehabilitation services market size was valued at USD 270.58 billion in 2024 and is predicted to hit around USD 463.79 billion by 2033, a study published by Towards Healthcare a sister...
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, in collaboration with its Canadian partner HLS Therapeutics, a...
Single-Cell Biotherapeutics Market: Trends, Growth Drivers and Regional Insights (2025–2034)
Ottawa, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The global single-cell biotherapeutics market is experiencing robust growth and is expected to reach hundreds of millions in revenue between 2025 and 2034. This expansion is driven by shifting consumer...
Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results
Press Release – No. 7 / 2025 Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results Copenhagen, Denmark, May 1, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a...